These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 7115451)

  • 41. OM-8980 and D-penicillamine in the treatment of rheumatoid arthritis. A 12-month double-blind randomized study.
    Verstraeten A; Sileghem A; Dequeker J
    Scand J Rheumatol; 1990; 19(6):422-31. PubMed ID: 2259898
    [TBL] [Abstract][Full Text] [Related]  

  • 42. D-penicillamine withdrawal in rheumatoid arthritis.
    Ahern MJ; Hall ND; Case K; Maddison PJ
    Ann Rheum Dis; 1984 Apr; 43(2):213-7. PubMed ID: 6370151
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Multicentric ambulatory trial of Trolovol (D-penicillamine) in chronic polyarthritis].
    Tautz VI
    Z Rheumatol; 1975; 34(3-4):87-93. PubMed ID: 806188
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effect of penicillamine on the blood serum copper level and acute phase tests in patients with rheumatoid arthritis].
    Rudy J; Sarosiek J
    Reumatologia; 1978; 16(2):237-44. PubMed ID: 694258
    [No Abstract]   [Full Text] [Related]  

  • 45. Clinical evaluation of D-penicillamine by multicentric double-blind comparative study in chronic rheumatoid arthritis.
    Shiokawa Y; Horiuchi Y; Honma M; Kageyama T; Okada T; Azuma T
    Arthritis Rheum; 1977; 20(8):1464-72. PubMed ID: 144507
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tiopronin-nephropathy: clinical, pathological, immunological and immunogenetic characteristics.
    Ferraccioli GF; Peri F; Nervetti A; Mercadanti M; Cavalieri F; Dall'Aglio PP; Savi M; Ferrari C
    Clin Exp Rheumatol; 1986; 4(1):9-15. PubMed ID: 3516496
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma zinc and its relationship to clinical symptoms and drug treatment in rheumatoid arthritis.
    Balogh Z; El-Ghobarey AF; Fell GS; Brown DH; Dunlop J; Dick WC
    Ann Rheum Dis; 1980 Aug; 39(4):329-32. PubMed ID: 7436558
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A 12-month comparative trial of auranofin and D-penicillamine in rheumatoid arthritis.
    Felix-Davies DD; Stewart AM; Wilkinson BR; Bateman JR; Delamere JP
    Am J Med; 1983 Dec; 75(6A):138-41. PubMed ID: 6419596
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A comparative trial of timegadine and D-penicillamine in rheumatoid arthritis.
    Mbuyi-Muamba JM; Dequeker J
    Clin Rheumatol; 1983 Dec; 2(4):369-74. PubMed ID: 6678197
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Some pharmacological properties of tiopronin.
    Capasso F
    Agents Actions; 1981 Dec; 11(6-7):741-5. PubMed ID: 7340466
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A study of adjunctive copper sulphate treatment in patients with rheumatoid arthritis who have relapsed while taking D-penicillamine.
    Pullar T; Wrigley H; Newton K; Toothill C; Wright V
    Br J Clin Pharmacol; 1991 Jan; 31(1):105-7. PubMed ID: 2015161
    [TBL] [Abstract][Full Text] [Related]  

  • 52. IgG and IgM rheumatoid factors in rheumatoid arthritis. Quantitative response to penicillamine therapy and relationship to disease activity.
    Wernick R; Merryman P; Jaffe I; Ziff M
    Arthritis Rheum; 1983 May; 26(5):593-8. PubMed ID: 6847722
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Toxicity of longterm low dose D-penicillamine therapy in rheumatoid arthritis. Cooperative Systematic Studies of Rheumatic Disease Group.
    J Rheumatol; 1987 Feb; 14(1):67-73. PubMed ID: 2952797
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Radiological progression in rheumatoid arthritis: do D-penicillamine and hydroxychloroquine have different effects?
    Scott DL; Greenwood A; Davies J; Maddison PJ; Maddison MC; Hall ND
    Br J Rheumatol; 1990 Apr; 29(2):126-7. PubMed ID: 2182170
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Controlled trial of hydroxychloroquine and D-penicillamine singly and in combination in the treatment of rheumatoid arthritis.
    Bunch TW; O'Duffy JD; Tompkins RB; O'Fallon WM
    Arthritis Rheum; 1984 Mar; 27(3):267-76. PubMed ID: 6367750
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [D-penicillamine in the treatment of rheumatoid polyarthritis. 104 cases with a 5-year follow-up].
    Valat JP; Fouquet B; Eveleigh MC; Chantreuil C; Lalot F
    Rev Rhum Mal Osteoartic; 1986 Jan; 53(1):7-12. PubMed ID: 3704516
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Tolerability and therapeutic maintenance of tiopronin, new basic treatment of rheumatoid arthritis. Apropos of long-term follow-up of 268 cases].
    Delecoeuillerie G
    Rev Rhum Mal Osteoartic; 1989 Apr; 56(5 Pt 2):38-42. PubMed ID: 2740804
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Low-dose D-penicillamine therapy in rheumatoid arthritis. A controlled, double-blind clinical trial.
    Williams HJ; Ward JR; Reading JC; Egger MJ; Grandone JT; Samuelson CO; Furst DE; Sullivan JM; Watson MA; Guttadauria M; Cathcart ES; Kaplan SB; Halla JT; Weinstein A; Plotz PH
    Arthritis Rheum; 1983 May; 26(5):581-92. PubMed ID: 6342625
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Thiopronine-induced pemphigus vulgaris in rheumatoid arthritis.
    Trotta F; Scaramelli M; Cervi G; Virgili AR
    Scand J Rheumatol; 1984; 13(1):93-5. PubMed ID: 6719065
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Treatment of common rheumatoid polyarthritis with D-penicillamine. Study of a series of 22 cases].
    Lièvre JA; Camus JP; Bénichou C; Guillien P; Crouzet J
    Ann Med Interne (Paris); 1971 May; 122(5):655-62. PubMed ID: 5563719
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.